Segui
Fabrizio Mattei
Titolo
Citata da
Citata da
Anno
Type I interferons produced by dendritic cells promote their phenotypic and functional activation
M Montoya, G Schiavoni, F Mattei, I Gresser, F Belardelli, P Borrow, ...
Blood, The Journal of the American Society of Hematology 99 (9), 3263-3271, 2002
6712002
IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation
F Mattei, G Schiavoni, F Belardelli, DF Tough
The Journal of Immunology 167 (3), 1179-1187, 2001
5782001
Classification of current anticancer immunotherapies
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ...
Oncotarget 5 (24), 12472, 2014
5542014
ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8α+ Dendritic Cells
G Schiavoni, F Mattei, P Sestili, P Borghi, M Venditti, HC Morse III, ...
The Journal of experimental medicine 196 (11), 1415-1425, 2002
5012002
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
E Vacchelli, Y Ma, EE Baracco, A Sistigu, DP Enot, F Pietrocola, H Yang, ...
Science 350 (6263), 972-978, 2015
4382015
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis
G Schiavoni, A Sistigu, M Valentini, F Mattei, P Sestili, F Spadaro, ...
Cancer research 71 (3), 768-778, 2011
3872011
Eosinophils: The unsung heroes in cancer?
G Varricchi, MR Galdiero, S Loffredo, V Lucarini, G Marone, F Mattei, ...
Oncoimmunology 7 (2), e1393134, 2018
2412018
Cyclophosphamide induces type I interferon and augments the number of CD44hi T lymphocytes in mice: implications for strategies of chemoimmunotherapy of …
G Schiavoni, F Mattei, T Di Pucchio, SM Santini, L Bracci, F Belardelli, ...
Blood, The Journal of the American Society of Hematology 95 (6), 2024-2030, 2000
2402000
IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
V Lucarini, G Ziccheddu, I Macchia, V La Sorsa, F Peschiaroli, C Buccione, ...
Oncoimmunology 6 (6), e1317420, 2017
1762017
The tumor microenvironment: a pitch for multiple players
G Schiavoni, L Gabriele, F Mattei
Frontiers in oncology 3, 90, 2013
1722013
Type I interferons as stimulators of DC-mediated cross-priming: impact on anti-tumor response
G Schiavoni, F Mattei, L Gabriele
Frontiers in immunology 4, 75041, 2013
1682013
Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment
L Businaro, A De Ninno, G Schiavoni, V Lucarini, G Ciasca, A Gerardino, ...
Lab on a Chip 13 (2), 229-239, 2013
1612013
Type I IFNs control antigen retention and survival of CD8α+ dendritic cells after uptake of tumor apoptotic cells leading to cross-priming
S Lorenzi, F Mattei, A Sistigu, L Bracci, F Spadaro, M Sanchez, M Spada, ...
The Journal of Immunology 186 (9), 5142-5150, 2011
1502011
Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules
Z Boussadia, J Lamberti, F Mattei, E Pizzi, R Puglisi, C Zanetti, L Pasquini, ...
Journal of Experimental & Clinical Cancer Research 37, 1-15, 2018
1332018
ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells
G Schiavoni, F Mattei, P Borghi, P Sestili, M Venditti, HC Morse III, ...
Blood 103 (6), 2221-2228, 2004
1332004
The pleiotropic immunomodulatory functions of IL-33 and its implications in tumor immunity
C Afferni, C Buccione, S Andreone, MR Galdiero, G Varricchi, G Marone, ...
Frontiers in immunology 9, 2601, 2018
912018
Cancer-driven dynamics of immune cells in a microfluidic environment
E Agliari, E Biselli, A De Ninno, G Schiavoni, L Gabriele, A Gerardino, ...
Scientific reports 4 (1), 6639, 2014
902014
Organs on chip approach: a tool to evaluate cancer-immune cells interactions
E Biselli, E Agliari, A Barra, FR Bertani, A Gerardino, A De Ninno, ...
Scientific reports 7 (1), 12737, 2017
832017
Combining type i interferons and 5-aza-2′-deoxycitidine to improve anti-tumor response against melanoma
V Lucarini, C Buccione, G Ziccheddu, F Peschiaroli, P Sestili, R Puglisi, ...
Journal of Investigative Dermatology 137 (1), 159-169, 2017
772017
IL-33 promotes CD11b/CD18-mediated adhesion of eosinophils to cancer cells and synapse-polarized degranulation leading to tumor cell killing
S Andreone, F Spadaro, C Buccione, J Mancini, A Tinari, P Sestili, ...
Cancers 11 (11), 1664, 2019
652019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20